Small Stocks, Big Money™

ConnectM Technology Solutions (Nasdaq: CNTM) continues its aggressive balance sheet transformation, retiring $9M in debt this month and slashing its annual interest expense by 90%. With $40M in liabilities wiped out since its July 2024 public debut, the company now carries under $8M in debt and expects to achieve positive stockholder equity by Q2 2025—bolstering its position as a tech-forward leader in the energy economy.

Gorilla Technology (Nasdaq: GRRR) has filed a lawsuit against Culper Research and its founder over what it calls a “brazen and nefarious” short report filled with false and defamatory claims. Seeking damages, the company is standing firm to protect shareholders, restore market confidence, and defend the integrity of its AI-driven smart city and security tech solutions.

XTI Aerospace (Nasdaq: XTIA) capped off a transformative 2024 with major advances in its TriFan 600 VTOL aircraft program, a strengthened IP portfolio, and the formal launch of its FAA type certification process in early 2025. With a $24M capital raise, Mesa Airlines on board for up to 100 aircraft, and strategic leadership expansion, XTI is poised to reopen pre-orders this year and cement its role at the forefront of the vertical air mobility revolution.

Can-Fite has outlined a robust revenue forecast of approximately $685M tied to existing global partnerships for its lead drug candidates, Piclidenoson and Namodenoson. Targeting high-value indications like psoriasis, advanced liver cancer, pancreatic cancer, and MASH, these agreements span milestone payments, royalties, and commercial sales—highlighting the biotech’s deep pipeline and strategic positioning ahead of potential regulatory approvals between 2027 and 2029.